The Journal of Clinical Endocrinology & Metabolism · 2013 · 51 citations · 28 references
MedicineEndocrinologyHormone BiochemistryReproductive EndocrinologyReproductive PhysiologyCongenital Endocrine DisordersEndocrine DiagnosticsGonadal EndocrinologyGonadal HormonesHypothalamic-pituitary-gonadal AxisMale Reproductive EndocrinologyGonadal Hormone AssaysHormonal AlterationsHypothalamic-pituitary-gonadal Axis DysfunctionInsulin-like Peptides
CONTEXT: Insulin-like factor 3 (INSL3) is a testicular hormone secreted during fetal life, the neonatal period, and after puberty. OBJECTIVE: To measure INSL3 levels in a large series of men with congenital hypogonadotropic hypogonadism (CHH)/ Kallmann syndrome (KS), in order to assess its diagnostic value and to investigate its regulation. PATIENTS: We studied 281 CHH/KS patients (91 untreated, 96 receiving T, and 94 receiving combined gonadotropin therapy [human chorionic gonadotropin, hCG, and FSH]) and 72 age-matched healthy men. METHODS: Serum INSL3 was immunoassayed with a validated RIA. RESULTS: Mean (±SD) INSL3 levels (pg/mL) were 659 ± 279 in controls and lower (60 ± 43; P < .001) in untreated CHH/KS patients, with no overlap between the two groups, when the threshold of 250 pg/mL was used. Basal INSL3 levels were lower in both untreated CHH/KS men with cryptorchidism than in those with intrascrotal testes and in patients with testicular volumes below 4 mL. Significant positive correlations between INSL3 and both serum total T and LH levels were observed in untreated CHH/KS. Mean INSL3 levels remained low in T-treated CHH/KS patients and were significantly higher in men receiving combined hCG-FSH therapy (P < .001), but the increase was lower cryptorchid patients. FSH-hCG combination therapy or hCG monotherapy, contrary to T and FSH monotherapies, significantly increased INSL3 levels in CHH/KS. CONCLUSIONS: INSL3 is as sensitive a marker as T for the evaluation of altered Leydig cell function in CHH/KS patients. INSL3 levels correlate with LH levels in CHH/KS men showing, together with the rise in INSL3 levels during hCG therapy, that INSL3 secretion seems not constitutively secreted during adulthood but is dependence on pituitary LH.
28
Cryptorchidism in mice mutant for Insl3
Serge Nef, Luis F. Parada · Nature Genetics · 1999 · 742 citations
Targeted Disruption of the Insl3 Gene Causes Bilateral Cryptorchidism
Stephan Zimmermann, Gerd Steding, Judith M. A. Emmen et al. · Molecular Endocrinology · 1999 · 684 citations · Full text
Reversal of Idiopathic Hypogonadotropic Hypogonadism
Taneli Raivio, John Falardeau, Andrew Dwyer et al. · New England Journal of Medicine · 2007 · 411 citations · Full text
Medicine, Endocrinology, Infertility +13